Use of Risk Factors To Select Adjuvant Therapy Versus Surveillance for Testicular Nonseminoma and Seminoma Germ Cell Tumors

Gedske Daugaard*, Jakob Lauritsen, Mikkel Bandak, Mads Agerbæk, Anne B Als, Lars Dysager, Birgitte G Toft, Birte Engvad, Daniel M Berney, Thomas Wagner

*Corresponding author af dette arbejde
2 Citationer (Scopus)

Abstract

New risk factors associated with relapse of stage I testicular cancer have been identified. These new factors reflect the risk of recurrence much better than previous parameters and can be used to assess the possible effect of adjuvant chemotherapy.

OriginalsprogEngelsk
TidsskriftEuropean Urology Focus
Vol/bind10
Udgave nummer3
Sider (fra-til)359-360
Antal sider2
ISSN2405-4569
DOI
StatusUdgivet - maj 2024

Fingeraftryk

Dyk ned i forskningsemnerne om 'Use of Risk Factors To Select Adjuvant Therapy Versus Surveillance for Testicular Nonseminoma and Seminoma Germ Cell Tumors'. Sammen danner de et unikt fingeraftryk.

Citationsformater